C Rad (CRAD B.ST) Hisse Fiyat
C Rad Fiyat
C Rad, son 17 yılda gelirini yıllık %41,0 artırarak 441,90 M SEK seviyesine taşıdı. Hisse başına kâr, son 7 yılda yıllık %10,7 geriledi. C Rad için net marj, %2,4 ile birkaç yıl önceki %9,6 seviyesine göre geriledi. C Rad için 12 aylık konsensüs fiyat hedefi 44,88 SEK; bu, hissenin bugünkü fiyatının yaklaşık %93,4 üzerinde bir seviyeye denk geliyor. 5 analistten 4 tanesi hisse için alım öneriyor — genel konsensüs: Al.
C Rad hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
C Rad iş modeli ve hisse analizi
C Rad hakkında sık sorulan sorular
The business model of C Rad AB is focused on providing innovative and advanced medical imaging solutions. C Rad AB is a company that specializes in developing and selling products for the radiation therapy market. They offer a range of solutions including advanced imaging tools and software designed to enhance the accuracy and efficiency of radiation therapy treatments. With a strong commitment to research and development, C Rad AB aims to provide healthcare professionals with cutting-edge technology that improves patient outcomes.
C Rad AB is primarily active in the medical technology industry.
The main competitors of C Rad AB in the market include Elekta AB, Varian Medical Systems Inc., and Accuray Incorporated.
C Rad AB is a Swedish medical technology company that specializes in innovative solutions for cancer treatment. Founded in 2004, C Rad AB has a rich history of developing advanced products for radiation therapy. With a strong focus on improving patient care, the company offers cutting-edge solutions like the C-RAD Catalyst system, which enhances accuracy and efficiency in radiotherapy. The company's commitment to research and development has made C Rad AB a trusted name in the field of oncology. With a vision to revolutionize cancer treatment, C Rad AB continues to make significant contributions to the medical industry through its state-of-the-art technologies and solutions.
C Rad AB has achieved several significant milestones since its inception. The company successfully developed innovative medical solutions, focusing on advanced imaging systems for radiation therapy. C Rad AB has gained notable recognition for its cutting-edge technologies and has received various awards for its exceptional contributions to the field. Additionally, the company has achieved significant collaborations with leading medical institutions and established a global presence by expanding its operations into multiple countries. C Rad AB continues to push boundaries, providing state-of-the-art solutions that enhance precision and safety in radiation therapy treatments.
C Rad AB is primarily present in Sweden.
C Rad AB represents values such as innovation, quality, and sustainability. As a company, C Rad AB is committed to delivering cutting-edge technology and solutions in the field of advanced radiation therapy. With a focus on developing and commercializing innovative products, C Rad AB aims to improve cancer treatment outcomes and enhance patient care. The company's corporate philosophy revolves around continuous research and development, collaboration with healthcare professionals, and a customer-centric approach. C Rad AB strives to make a positive impact on society by providing state-of-the-art solutions that contribute to the advancement of cancer care.
Analistler şu anda C Rad hissesi için ortalama 44,88 SEK hedef fiyat belirliyor (medyan: 44,88 SEK); bu, son fiyata göre +111,7 % anlamına gelir. Konsensüs 5 analist notuna dayanır.
5 analist şu anda C Rad hissesini değerlendiriyor: 4 al, 1 tut, 0 sat öneriyor. 2026 için analistler C Rad şirketinin 463,88 M SEK gelir ve 2,28 SEK hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla C Rad hissesi 2,11 EUR (23,20 SEK) seviyesindedir.
C Rad hissesi (CRAD B.ST) 4 borsada işlem görür, bunlar arasında: London (0R44.L), Frankfurt (24C.F), Stockholm (CRAD B.ST).
The company C Rad AB is a leading provider of digital radiology and medical technology solutions. The company offers a wide range of products and services tailored to the needs of patients, doctors, and hospitals. One of the core divisions of C Rad AB is the development and manufacture of digital radiology systems, including Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and digital X-ray systems. These systems are capable of creating precise images of tissues and organs while enabling minimally invasive treatments. C Rad AB aims to improve patient care by focusing on the development of systems that enable precise and fast diagnoses. Another important business area is the development of medical software solutions. C Rad AB has developed a range of tools for digitally capturing, archiving, and analyzing radiological images. These analysis tools allow radiologists to make fast diagnoses and plan effective treatments. The software solutions also include a platform for data exchange and collaboration, making it easier for doctors and clinics to share patient images and data. C Rad AB also operates a number of diagnostic centers that offer a comprehensive range of health services. These centers provide rapid tests, radiology services, laboratory diagnostics, and other medical services. The centers are equipped with state-of-the-art technology and provide fast and accurate diagnoses for patients. Finally, C Rad AB also offers a variety of training and support services for patients and medical professionals. The company operates its own training academy, offering training for radiologists and medical personnel. Additionally, the company provides technical support and maintenance services for its products. Overall, the business model of C Rad AB is focused on offering innovative solutions for radiology and digital medicine. The company has a strong research and development department that is constantly working on new technologies and solutions. By combining top-quality products, services, and training, C Rad AB has strengthened its position as a leading provider of medical technology solutions.
beklenen'nin C Rad hasılatı 463,88 M SEK'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin C Rad karı 77,23 M SEK'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
C Rad'nin Fiyat/Kazanç (F/K) oranı şu anda 10,15'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların C Rad hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
C Rad'nin Fiyat/Satış (F/S) oranı şu anda 1,69'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve C Rad hisse senedinin değerleme metriği olarak hizmet eder.
C Rad'nin Eulerpool Kalite Puanı 5/10'dur.
C Rad'nin ISIN'i SE0002016352'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
C Rad'nin WKN'i A0X93X'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
C Rad'nin ticker'ı CRAD B.ST'dir. Ticker sembolü, C Rad hisseleri borsada işlem görmek için kullanılır.
C Rad Hissesi
C Rad Emsaller Grubu
C Rad Ticker
C Rad FIGI
C Rad'nin tüm temel göstergeleri ve derinlemesine analizi
C Rad hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve C Rad şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: